Recombinant herpes simplex gb-gd vaccine

Details Recombinant herpes simplex gb-gd vaccine Recombinant herpes simplex gb-gd vaccine

A - Human Necessities

61

K

167/130

A61K 39/245 (2006.01) A61K 39/39 (2006.01) C07K 14/035 (2006.01) A61K 39/00 (2006.01)

Patent

CA 1337395

Vaccines and therapeutic compositions useful for therapeutic treatment of disease caused by Herpes Simplex Virus (HSV) are provided. These vaccines and compositions employ recombinant HSV glycoproteins B and D. Treatment of an HSV infected individual with the vaccine or composition subsequent to infection with HSV alleviates recurrent disease due to HSV, even if the individual is treated during an acute phase of the disease when HSV induced lesions are present.

549786

Affiliated with

Also associated with

Rating

Recombinant herpes simplex gb-gd vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Recombinant herpes simplex gb-gd vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant herpes simplex gb-gd vaccine will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1330871